Advanced Search

ICD-10-CM Code for Adverse effect of antineoplastic and immunosuppressive drugs, sequela T45.1X5S

ICD-10 code T45.1X5S for Adverse effect of antineoplastic and immunosuppressive drugs, sequela is a medical classification as listed by WHO under the range - Injury, poisoning and certain other consequences of external causes .

Image 2

Official Long Descriptor

Adverse effect of antineoplastic and immunosuppressive drugs, sequela

T45.1

Excludes1: poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs (T45.A)
poisoning by, adverse effect of and underdosing of tamoxifen (T38.6)

Additional/Related Information

Tabs
Get crucial instructions for accurate ICD-10-CM T45.1X5S coding with all applicable Excludes 1 and Excludes 2 notes from the section level conveniently shown with each code.
This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code.

Crosswalks

Forum

Have a question about ICD-10-CM Code T45.1X5S ? Start a discussion here
Coding for radiation therapy polyneuropathy
We are a pain management clinic and have a patient who was diagnosed with cancer which was removed and followed with radiation. She now has polyneuropathy due to this. The most logical external-cause ... [ Read More ]
adverse effects from Velcade
[b]Velcade[/b] I want to say thank you to Debra A. Mitchell. Your reply really helped me out. I came up with ICD-10 (T45.1X5S) for adverse effect from Velcade (Bortezomib) by looking up the agent ... [ Read More ]
Coding E933.1 for ICD 10
In chemotherapy we use E933.1. I am trying to figure out whether we would use T45.1X5S or T45.1X5D when a patient receiveds Neupogen/Neulasta after chemotherapy. All of the crosswalks and mapping st... [ Read More ]
View All

Coding Alert(s)

    See links to CMS documents related to your ICD-10-CM code without changing pages or searching the Web. Create your account here for Free Trial to Codify's CMS Center!

    Latest News